• Best stocks to buy now
  • Disclaimer
  • Media Coverage
Monday, December 4, 2023
No Result
View All Result
Best Stocks
  • News
  • Best stocks to buy now
  • Categories
    • Crypto
    • Dow Jones today
    • Pre-IPO and startups
    • Tech stocks
    • Utility stocks
  • Best Stocks toolsHOT
    • Stock News Sentiment
    • Stock Fundamentals Checker
    • Price Targets
    • Social Sentiments Checker
    • Indices
  • About us
    • About
    • Contact
Best Stocks
No Result
View All Result
Home News

Anticipated Earnings and Stock Performance for MediWound

Elaine Mendonça by Elaine Mendonça
November 20, 2023
in News
Reading Time: 3 mins read
A A
0
Pharmaceuticals stock today
0
SHARES
8
VIEWS
Share on FacebookShare on Twitter

Unique Version:

Anticipated Earnings for MediWound

MediWound, a company listed on the NASDAQ under the ticker MDWD, is set to disclose its quarterly earnings on November 21, 2023. Analysts have projected an earnings per share (EPS) of $-0.44 for the company. It is worth noting that while surpassing or falling short of earnings expectations can impact stock prices, the guidance provided for future performance can also significantly influence investor sentiment.

Past Earnings Performance

In the previous quarter, MediWound exceeded EPS projections by $0.51. Surprisingly, the stock price experienced a 1.54% decline the following day. To provide a comprehensive overview of the company’s historical performance, here are the earnings figures and corresponding price changes:

Quarter EPS Estimate EPS Actual Price Change %
Q2 2023 -0.41 0.10 -1.54%
Q1 2023 -0.30 -0.44 1.56%
Q4 2022 -0.59 -1.18 2.63%
Q3 2022 -0.56 -0.91 -10.78%

Stock Performance

As of November 17, MediWound’s shares were trading at $8.33, representing a significant 22.68% decrease over the past 52 weeks. Given the negative returns, long-term shareholders may have concerns regarding the upcoming earnings announcement.

In summary, investors are eagerly awaiting MediWound’s earnings report, placing emphasis on both the EPS figures and the company’s guidance for future performance.

MediWound Ltd.

MDWD

Neutral

Updated on: 04/12/2023

Financial Health

Weak


Debt to equity ratio: Strong Buy

Price to earnings ratio: Strong Sell

Price to book ratio: Strong Buy

DCF: Strong Buy

ROE: Strong Sell

Show more

Price Target

Current $8.85

Concensus $24.33


Low $23.00

Median $25.00

High $25.00

Show more

Social Sentiments

8:00 PM (UTC)

Date:01 December, 2023

0
Twitter Sentiment

0.5
Stocktwits Sentiment

Show more

Analyst Ratings

Analyst / firm Rating
H.C. Wainwright Buy
Cowen & Co. Buy
Maxim Group Buy
H.C. Wainwright Sell
Show more

MDWD Stock Analysis: Positive Growth in Earnings and Revenue, Despite Negative Net Profit Margin

On November 20, 2023, MDWD (MediWound Ltd.) stock opened at $8.50 and fluctuated between $8.50 and $8.85 throughout the day. The trading volume was 1,109 shares, significantly lower than the average volume over the past three months. MDWD has a market capitalization of $71.4 million and has shown positive growth in earnings and revenue this year. However, it has a negative net profit margin of -73.97%. The price-to-sales ratio is 2.54 and the price-to-book ratio is 5.61. On that day, MDWD stock increased by $0.05, resulting in a percentage change of +3.11%. Comparatively, SCYX and THTX also saw increases of $0.05, with percentage changes of +3.82% and +3.11% respectively. AFMD experienced a more significant increase of $0.07, resulting in a percentage change of +17.17%, while LOVF saw a decrease of $0.01, resulting in a percentage change of -1.03%. The next reporting date for MDWD is on November 21, 2023, with an anticipated earnings per share (EPS) of -$0.39 for the current quarter. MDWD reported annual revenue of $26.5 million and an annual profit of -$19.6 million for the previous year.

Mediwound Ltd (MDWD) Stock Shows Promising Future with Analysts Predicting Significant Increase in Target Price

On November 20, 2023, Mediwound Ltd (MDWD) stock performed well, with analysts predicting a promising future for the company. According to data from CNN Money, four analysts offered 12-month price forecasts for MDWD, with a median target of 25.50. The high estimate was 36.00, while the low estimate was 25.00. This median estimate represents a significant increase of 188.14% from the last recorded price of 8.85.

The consensus among the four polled investment analysts is to buy stock in Mediwound Ltd. This rating has remained steady since December, indicating a consistent belief in the company’s potential.

Examining the current quarter’s financials, Mediwound Ltd reported a loss of $0.39 per share. However, the company’s sales reached $5.0 million, suggesting a healthy revenue stream.

Investors should note that Mediwound Ltd is set to report its earnings for the current quarter on November 21, 2023. This upcoming report may provide further insights into the company’s financial performance and future prospects.

Based on the information provided, Mediwound Ltd appears to be an attractive investment opportunity. With the median target price forecasted to increase by 188.14% and a consensus “buy” rating from analysts, there is a positive sentiment surrounding MDWD stock. However, investors should conduct their own research and consider various factors before making any investment decisions.

It is essential to keep in mind that stock market performance can be volatile, and past performance is not always indicative of future results. Therefore, it is crucial to exercise caution and consult with a financial advisor or conduct thorough research before making any investment decisions.

Tags: MDWD
Elaine Mendonça

Elaine Mendonça

Over the last nine years, Elaine has managed investment portfolio using fundamental analysis and value investing, emphasizing long-term time horizons.

Discussion about this post

DISCLAIMER

Nothing on this website should be considered personalized financial advice. Any investments recommended here in should be made only after consulting with your personal investment advisor and only after performing your own research and due diligence, including reviewing the prospectus or financial statements of the issuer of any security.

The Best Stocks, its managers, its employees, affiliates and assigns (collectively “The Company”) do not make any guarantee or warranty about the advice provided on this website or what is otherwise advertised above.

READ MORE

Categories

Best Stocks to buy now
Crypto
Dow Jones Today
Pre-IPO and Startups
Tech stocks
Utility Stocks

Data and Tools
Stock Forecast
Dow Jones Today

Follow us on Social Media
Facebook – YouTube – Twitter

Write for us
Finance – Business

Best Stocks to Buy Now

We are a financial media dedicated to providing stock recommendations, news, and real-time stock prices.

  • Disclaimer
  • Privacy Policy
  • Best stocks to buy now
  • Contact
  • Write for us – Finance, Crypto

© 2023 Best Stocks

No Result
View All Result
  • Home
  • News
  • Best stocks to buy now
  • Categories
    • Crypto
    • Dow Jones Today
    • Pre-IPO and Startups
    • Tech stocks
    • Utility Stocks
  • Best Stocks Tools
    • Stock News Sentiment
    • Stock Fundamentals Checker
    • Price Targets
    • Social Sentiments Checker
    • Indices
  • About us
    • About
    • Contact

© 2023 Best Stocks